OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 02, 2019
Establishing OEL data and ensuring appropriate engineering controls are crucial aspects of safe handling.
October 01, 2019
An understanding-during early development-of the solid form landscape of an API can enhance product quality and manufacturing processes.
New therapies, new technologies, global supply chain challenges, and political pressures draw pharma professionals to major industry event.
September 13, 2019
Bora Pharmaceuticals has announced it has achieved success in the latest FDA general inspection of its Zhunan facility with zero 483 observations.
September 11, 2019
FDA issued a statement about the importance of reporting adverse events resulting from the use of compounded drugs.
September 09, 2019
The new antibody, Citryll’s CIT-013, could offer new treatment options for various human diseases including lupus, vasculitis, pulmonary fibrosis, and organ damage due to sepsis.
September 02, 2019
The editors welcome technical article contributions from the bio/pharma industry.
September 01, 2019
CDMOs are adding facilities and services to their portfolios in anticipation of the biologics industry’s continued growth.
August 30, 2019
Alvotech and Prestige Biopharma, have announced the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.
August 15, 2019
The latest research from GlobalData has revealed that more than two-thirds (69%) of CMOs high-containment facilities are based in the top five European Union countries and Switzerland.